Yan Zhang currently serves as the President of Bruker Cellular Analysis, focusing on innovative cellular analysis technologies that enhance therapeutic development. Previously, Yan held the position of Chief Commercial Officer at PhenomeX, driving advancements in functional cell biology tools, and served as the Chief Executive Officer of Mission Bio, where leadership of the Tapestri Platform was pivotal in high-throughput single-cell multiomics. Yan's experience includes significant roles at Thermo Fisher Scientific, Life Technologies, NuGEN Technologies, Affymetrix, Molecular Devices, and Hyseq, with a strong track record in product marketing and business development in the life sciences industry. Yan holds a Ph.D. in Molecular Biology from the Medical College of Wisconsin and a Bachelor of Science in Biochemistry from Peking University.